Диссертация (1140786), страница 17
Текст из файла (страница 17)
– Vol.50, №24. – Р.2275-84.58.Feng J, Schaus BJ, Fallavollita JA et al. Preload induces troponin Idegradation independently of myocardial ischemia. Circulation 2001;103:2035–7.59.Filippi CR, Lemos JA, Christenson RH et al.. Association of serial measures ofcardiac troponin T using a sensitive assay with incident heart failure and cardiovascularmortality in older adults. JAMA 2010;304:2494 –502.60.Fred Kusumoto MD; ICDs for Primary Prevention of Death in Left VentricularDysfunction Published in Cardiology Journal, March 02, 201761.Frohlich GM, Holzmeister J, Hubler M, Hubler S, Wolfrum M, Enseleit F, SeifertB, Hurlimann D, Lehmkuhl HB, Noll G, Steffel J, Falk V, Luscher TF, Hetzer R,Ruschitzka F. Prophylactic implantable cardioverter defibrillator treatment in patientswith end-stage heart failure awaiting heart transplantation.
Heart 2013;99: 1158–1165.62.Gabriele Castelli, Alessandra Fornaro, Mauro Ciaccheri, Alberto Dolara, VitoTroiani, Benedetta Tomberli, Iacopo Olivotto, Gian Franco Gensini Improving SurvivalRates of Patients With Idiopathic Dilated Cardiomyopathy in Tuscany Over 3 DecadesImpact of Evidence-Based Management.
Circulation: Heart Failure. September 17,201363.Gao WD, Atar D, Liu Y et al. Role of troponin I proteolysis in the pathogenesisof stunned myocardium. CircRes 1997; 80:393–9.64.GoldbergerJJ,CainME,HohnloserSHet.al.AmericanHeartAssociation/American College of Cardiology Foundation/Heart Rhythm SocietyScientific Statement on Noninvasive Risk Stratification Techniques for IdentifyingPatients at Risk for Sudden Cardiac Death // Circulation.
– 2008. – Vol. 118. – P. 1497 1518.11365.Goldberger JJ, Subacius H, Patel T, Cunnane R, Kadish AH. Sudden cardiacdeath risk stratification in patients with nonischemic dilated cardiomyopathy. J Am CollCardiol 2014;63:1879–1889.66.Grimm W, Schmidt G, Maisch B, et al. Prognostic significance of heartrate turbulence following ventricular premature beats in patients with idiopathicdilated cardiomyopathy. // J Cardiovasc Electrophysiol. – 2003. –Vol.14.– P.819824.67.Grimm W., Sharkova J., Maisch B. Prognostic significance of heart rateturbulence in patients with idiopathic dilated cardiomyopathy // Europace. – 2002.–Vol.3, A153.
– P.146-152.68.Grimm W., Sharkova J., Christ M., and Maisch B. arrhythmia risk prediction inidiopath1c dilated cardiomyopathy based on heart rate variability and baroreflexsensitivity Department of Cardiology, Philipps-University Marburg, Germany.69.Ghuran A, Reid F, La Rovere MT, Schmidt G, Bigger JT Jr, Camm AJ,Schwartz PJ, Malik M; ATRAMI Investigator Heart rate turbulence-basedpredictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and ReflexesAfter Myocardial Infarction substudy).
//Am J Cardiol. –2002. – Vol.15;89,(2). –P.184-190.70.Hering HE. Das Wesen des Herzalternans. // Munchen Med Wochenshr. –1908. –Vol.4. –P1417-21.71.Hohnloser SH, Klingenheben T, Zabel M, et al. T wave alternans duringexercise and atrial pacing in humans. // J Cardiovasc Electrophysiol. – 1997. – Vol.8. –P.987–993.72.Hohnloser SH, Klingenheben T, Zabel M, Schopperl M, Mauss O. Prevalence,characteristics and prognostic value during long-term follow-up of nonsustainedventricular tachycardia after myocardial infarction in the thrombolytic era. //J AmColl Cardiol.
–1999. –Vol.33. –P.1895-902.73.Huikuri HV, Exner DV, Kavanagh KM, Aggarwal SG, Mitchell LB,Messier MD, Becker D, Sheldon RS, Bloch Thomsen PE; CARISMA and114REFINE Investigators. Attenuated recovery of heart rate turbulence early aftermyocardial infarction identifies patients at high risk for fatal or near-fatalarrhythmic events.//Heart Rhythm. –2010.–Vol.7,№2.
–P.229-35.74.Heart rate variability: standards of measurement, physiological interpretationand clinical use. Task Force of the European Society of Cardiology and theNorth American Society of Pacing and Electrophysiology. // Circulation. – 1996. –Vol.93. –P.1043-1065.75.Hallstrom AP, Stein PK, Schneider R, Hodges M, Schmidt G, Ulm K;CAST Investigators. Characteristics of heart beat intervals and prediction of death.//Int J Cardiol. –2005.
–Vol.8;100(1). –P.37-45.76.Haas J, Frese KS, Peil B, Kloos W, Keller A, Nietsch R, Feng Z, MullerS,Kayvanpour E, Vogel B, Sedaghat-Hamedani F, Lim WK, Zhao X, Fradkin D, KohlerD, Fischer S, Franke J, Marquart S, Barb I, Li DT, Amr A, Ehlermann P, Mereles D,Weis T, Hassel S, Kremer A, King V, Wirsz E, Isnard R, Komajda M, Serio A, GrassoM, Syrris P, Wicks E, Plagnol V, Lopes L, Gadgaard T, Eiskjaer H, Jorgensen M,Garcia-Giustiniani D, Ortiz-Genga M, Crespo-Leiro MG, Deprez RH, Christiaans I, vanRijsingen IA, Wilde AA, Waldenstrom A, Bolognesi M, Bellazzi R, Morner S, BermejoJL, Monserrat L, Villard E, Mogensen J, Pinto YM, Charron P, Elliott P, Arbustini E,Katus HA, Meder B. Atlas of the clinical genetics of human dilated cardiomyopathy.Eur Heart J 2015;36:1123–1135.77.Ikeda T, Miwa Y, Abe A, Nakazawa K. 10.1016/j.jelectrocard.2011.08.003.
Epub2011 Sep 9.Usefulness of heart rate urbulence for predicting cardiac events in patientswith nonischemic dilated cardiomyopathy. J Electrocardiol. 2011 Nov-Dec;44(6):66972.78.JaffeAS.Troponin--past,present,andfuture.CurrProblCardiol.2012;37(6):209-2879.Jaffe AS , Wu AHB Troponin Release—Reversible or Irreversible Injury? ShouldWe Care? Clinical Chemistry,2012, 58:1148–15011580.Kawahara C., Tsutamoto T., Nishiyama K.
et al. Prognostic role of high-sensitivity cardiac troponin T in patients with non ischemic dilated cardiomyopathy //Circ. J. 2011; 75(3): 656–66181.Kuck K. H., Cappato R., Siebels J., Ruppel R. Randomized comparison ofantiarrhythmic drug therapy with implantable defibrillators in patients resuscitated fromcardiac arrest //Circulation. 2000. Vol. 102.
P. 748–754.82.Kleber AG, Janse MJ, van Capelle FJ, et al: Mechanism and time course of STand TQ segment changes during acute regional myocardial ischemia in the pig heartdetermined by extracellular and intracellular recordings. // Circ Res. – 1978.
–Vol.42.–P. 603-613.83.Kleiger RE, Miller JP, Bigger JT: Decreased heart rate variability and itsassociation with increased mortality after acute myocardial infarction. //Am JCardiol. – 1987. – Vol.59. – P. 256-262.84.Klingenheben T, Grönefeld G, Li Y, et al. Effect of metoprolol and d,l-sotalol onmicrovolt-level T-wave alternans. // J Am Coll Cardiol. – 2001. – Vol.38. – P.20132019.85.Klingenheben T. Arrhythmia risk prediction in patients with preserved leftventricular function: The final frontier? // J Am Coll Cardiol.
– 2006. – Vol.48. –P.2275-2276.86.Kober L, Thune JJ, Nielsen JC, et al. Defibrillator implantation in patients withnonischemic systolic heart failure. N Engl J Med. 2016;375(13):1221-30.87.Konstantinos Karatolios A, Volker Holzendorf B, Anette Richter A, BernhardSchieffer A, Sabine Pankuweit A Long-term outcome and predictors of outcome inpatients with non-ischemic dilated cardiomyopathy, on behalf of the CompetenceNetwork Heart Failure Germany; International Journal of Cardiology 220 (2016) 608–61288.Lown B, Verrier RL. Neural activity and ventricular fibrillation. //N Engl J Med.–1976.2–Vol.94.
–P.1165-1170.11689.Lippi G, Montagnana M, Aloe R, Cervellin G. High sensitive troponinimmunoassays: navigating between the scylla and charybdis. Adv Clin Chem.2012;58:1-29.90.Lemos JA, Drazner MH, Omland T et al. Association of troponin T detected witha highly sensitive assay and cardiac structure and mortality risk in the generalpopulation. JAMA 2010; 304:2503–12.91.Lewek J, Wranicz JK, Guzik P, Chudzik M, Ruta J, Cygankiewicz I.Clinical and electrocardiographic covariates of deceleration capacity in patientswith ST-segment elevation myocardial infarction.
//Cardiol J. – 2009. –Vol.16,№6.–P.528-534.92.Mäkikallio T. H., Barthel P., Schneider R., Bauer A., Tapanainen J. M., TulppoM. P., Schmidt G., Huikuri H. V. Prediction of sudden cardiac death after acutemyocardial infarction; role of Holter monitoring in the modern treatment era.//Eur. Heart J.
–2005. –Vol.26. –P.762–769.93.Maron B.J. Contemporary Insights and Strategies for Risk Stratification andPrevention of Sudden Death in Hypertrophic Cardiomyopathy // Circulation. – 2010. –Vol. 121. – P. 445-456.94.Meune C, Van Berlo JH. Anselme F, et al. Primary prevention of sudden death inpatients with lamin A/C gene mutations. N Engl J Med 2006; 354: 209-210.95.McDonough JL, Arrell DK, Van Eyk JE. Troponin I degradation and covalentcomplex formation accompanies myocardial ischemia/ reperfusion injury. Circ Res1999;84:9 –20.96.McCarthy R.E., Boehmer J.P., Hruban R.H. et al.
Long-term outcome offulminant myocarditis as compared with acute (nonfulminant) myocarditis // N. Engl. J.Med. - 2000. - Vol. 342. - P. 690-695.97.McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, DicksteinK,Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY,Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH,Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA,Zannad F, Zeiher A. ESC117Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: TheTask Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 ofthe European Society of Cardiology.
Developed in collaboration with the Heart FailureAssociation (HFA) of the ESC. Eur Heart J 2012;33:1787–1847.98.Myerburg R. J., Kessler K. M., Castellanos A. Sudden cardiac death. Structure,function, and time dependence of risk // Circulation. 1992. Vol. 85. P. 12–20.99.Morley-Davies A., Dargie H.J., Cobbe S.M. et al. Heart rate turbulence: a novelholter derived measure and mortality in chronic heart failure // Eur. Heart J. – 2000. –Vol.21, Suppl. – P.408.100. Momiyama Y, Hartikainen J, Nagayoshi H, Albrecht P, Kautzner J, SaumarezRC, et al. Exercise-induced T-wave alternans as a marker of high risk in patientswith hypertrophic cardiomyopathy.
// Jpn Circ J. – 1997. – Vol.61. – P.650 -656.101. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. //In: Braunwald E, ed., Heart disease: a textbook of cardiovascular medicine.//NewYork: W B Saunders Publishing Co. – 1997. – P.742–779.102. Myerberg R. Sudden Cardiac Death: Exploring the limits or our knowledge.//Journal of Cardiovascular Electrophysiology. – 2001. – Vol.12. – P.369–381.103. Miyoshi S, Miyazaki T, Moritani K, et al: Different responses ofepicardium and endocardium to KATP channel modulators during regionalischemia. // Am J Physiol. –1996. –Vol.271.
–P.140-147.104. Narayan S.M. T-Wave Alternans and the Susceptibility to VentricularArrhythmias // J Am Coll Cardiol. – 2006. – Vol.47. – P.269-281.105. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heartfailure. N Engl J Med 1996; 335: 1182–9.106. Nearing B. D., Verrier R. L. Modifi ed moving average analysis of Twave alternans to predict ventricular fi brillation with high accuracy // J. Appl.Physiol. – 2002. – Vol. 92. – P.541-549.118107. Nieminen T, Lehtimäki T, Viik J, et al.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
